Search by Drug Name or NDC
NDC 00065-0085-15 Naphcon A .25; 3 mg/mL; mg/mL Details
Naphcon A .25; 3 mg/mL; mg/mL
Naphcon A is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE.
Product Information
| NDC | 00065-0085 |
|---|---|
| Product ID | 0065-0085_af7dc605-2d55-45bd-b2d9-c9ef0b6e30e6 |
| Associated GPIs | 86409902142010 |
| GCN Sequence Number | 023718 |
| GCN Sequence Number Description | naphazoline HCl/pheniramine DROPS 0.025-0.3% OPHTHALMIC |
| HIC3 | Q2H |
| HIC3 Description | EYE ANTIHISTAMINE-VASOCONSTRICTOR COMBINATIONS |
| GCN | 86003 |
| HICL Sequence Number | 003407 |
| HICL Sequence Number Description | NAPHAZOLINE HCL/PHENIRAMINE MALEATE |
| Brand/Generic | Brand |
| Proprietary Name | Naphcon A |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | naphazoline hydrochloride and pheniramine maleate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | .25; 3 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE |
| Labeler Name | Alcon Laboratories, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020226 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00065-0085-15 (00065008515)
| NDC Package Code | 0065-0085-15 |
|---|---|
| Billing NDC | 00065008515 |
| Package | 1 BOTTLE in 1 CARTON (0065-0085-15) / 15 mL in 1 BOTTLE |
| Marketing Start Date | 1995-01-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.5484 |
| Pricing Unit | ML |
| Effective Date | 2024-02-21 |
| NDC Description | NAPHCON-A EYE DROPS |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis